Vestal Point Capital’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.6M | Buy |
3,200,000
+1,499,931
| +88% | +$27.9M | 3.14% | 8 |
|
|
2025
Q1 | $30.8M | Buy |
1,700,069
+625,069
| +58% | +$11.3M | 2.2% | 16 |
|
|
2024
Q4 | $23.4M | Buy |
1,075,000
+680,000
| +172% | +$14.8M | 1.39% | 27 |
|
|
2024
Q3 | $10.8M | Sell |
395,000
-205,000
| -34% | -$5.61M | 0.82% | 29 |
|
|
2024
Q2 | $15.5M | Buy |
600,000
+145,000
| +32% | +$3.75M | 1.16% | 28 |
|
|
2024
Q1 | $13.7M | Buy |
455,000
+320,000
| +237% | +$9.6M | 1.13% | 23 |
|
|
2023
Q4 | $1.4M | Buy |
+135,000
| New | +$1.4M | 0.15% | 38 |
|